Protein Structure

Day 11 part 2

Quiz ChatGPT conversation

🧬 Why PTMs Matter (Proteoforms concept)

A single gene does not produce just one protein
PTMs create many proteoforms (functional variants)

👉 Implication:

Protein function is not determined by sequence alone
PTMs encode an additional regulatory layer

⚙️ Types of PTMs (Broader Perspective)

Beyond phosphorylation, the transcript emphasizes:

Oxidation → often stress-related
Methylation / acetylation → gene regulation, chromatin structure
Ubiquitination → protein degradation signal
Glycosylation → structural + signaling roles

👉 Important concept:

PTMs can be:
- Biological (in vivo)
- Artificial (introduced experimentally)

🧪 Chemical vs Biological Modifications

Not all detected modifications are “natural”

Examples:

Biological:
- Phosphorylation
- Glycosylation
Experimental:
- Carbamidomethylation (sample prep)
- Fluorescent labeling
- TMT tagging

👉 Insight:

You must always know:
- What was introduced experimentally
- vs.
- What is biologically relevant

🔗 Complementary Role of MS

MS is not standalone:

Can validate:
- Fluorescent labeling
- Chemical tagging
Provides independent confirmation

👉 Principle:

More independent evidence → stronger scientific conclusions

🔍 Fragmentation Pattern Logic (Deeper Insight)

Key principle:

Fragmentation produces predictable ion series

What really matters:

m/z positions, not intensity

👉 Important correction:

Intensity differences ≠ meaningful for identification
Position shifts = structural information

🧠 Localization of PTMs — Subtle Challenge

Even if you detect a modification:

Locating the exact residue can be difficult

Why:

Fragment spacing still corresponds to residue masses
The modification is “hidden” inside a fragment

👉 You detect:

“Something changed between these fragments”

But:

You must infer where exactly

🧮 De Novo vs Reference-Based Identification

Two strategies:

1. Reference-based

Compare to known peptide spectrum

2. De novo

Predict fragmentation pattern
Match experimentally

👉 Insight:

De novo is more flexible but harder and error-prone

⚡ Charge States in Fragmentation

You saw this partially, but here is the deeper point:

MS spectra can contain:
- Singly charged ions (1+)
- Doubly charged ions (2+)

Why this matters:

Doubly charged ions:
- Appear at lower m/z
- Can confuse interpretation

👉 In your course:

Focus is simplified → only singly charged ions

🔎 Missing Peaks (e.g., missing B8)

Observed phenomenon:

Some expected fragments are missing

Reasons:

Fragment not formed
Fragment unstable
Detection limit

👉 Important:

You do not need a complete series
Partial series is often sufficient

🧩 Search Space Problem in PTM Analysis

Critical concept:

More PTMs → more possibilities → harder analysis

Consequences:

Slower computation
Higher false positives

👉 Strategy:

Limit search to:
- Likely PTMs
- Specific residues

🧪 Enrichment Strategies (Expanded View)

You mentioned removal of unmodified peptides, but more broadly:

Types of enrichment:

Column-based
Resin-based
Antibody-based

Concept:

“Pull-down” of specific PTMs before MS

👉 Trade-off:

Less global overview
Much deeper insight into specific PTMs

📊 Global vs Targeted PTM Analysis

Global analysis:

Detect all modifications
Broad but shallow

Targeted analysis:

Focus on one PTM (e.g., phosphorylation)
Deep but narrow

👉 Core trade-off:

Breadth vs depth

🧬 Comparative PTM Analysis (Biological Insight)

MS allows comparison between conditions:

Control vs treated
Healthy vs diseased

What you can learn:

Which PTMs increase/decrease
Which pathways are activated

👉 Example from transcript:

Cytokine treatment → changes in:
- Phosphorylation
- Acetylation

🍬 Glycoproteomics — Why It’s Difficult (Expanded)

Problem 1: Structural complexity

Glycans are:
- Branched
- Highly variable

Problem 2: Combinatorial explosion

Many possible structures per site

Problem 3: Instability (labile)

Break during MS fragmentation

👉 Result:

Standard workflows fail
Requires specialized methods

⚖️ Core Limitation of Mass Spectrometry

You cannot have everything at once:

High complexity sample → low depth
Low complexity sample → high depth

👉 Fundamental constraint:

Instrument time and detection capacity are limited

🧠 Final Conceptual Summary

What MS-based PTM analysis really is:

Detect mass shifts
Map them to known modifications
Use fragment ions to localize the site
Use enrichment to reduce complexity
Interpret biological meaning

🔑 Big Picture Takeaways

PTMs are essential for functional diversity
MS detects PTMs via Δmass + fragmentation shifts
Identification depends on:
- Residue specificity
- Fragment pattern analysis
Major challenges:
- Search space explosion
- Labile modifications (glycans)
- Incomplete fragmentation
Experimental design (enrichment, constraints) is as important as analysis

Quiz

Score: 0/30 (0%)

Q0. In PTM analysis by mass spectrometry, why is the delta mass of a modification important?

It indicates the retention time of the peptide during chromatography.

It provides a measurable mass shift that can help identify the type of modification.

It tells whether the peptide is folded or unfolded in solution.

It directly identifies the protein sequence without fragmentation.

Q1. Why are PTMs described as important contributors to proteoforms?

Because they convert all proteins into DNA-binding proteins.

Because they create chemically distinct versions of the same protein after translation.

Because they prevent proteins from being detected by mass spectrometry.

Because they remove all sequence variation between proteins.

Q2. Which statement best describes residue specificity in PTM identification?

All PTMs can occur equally on all amino acids.

Residue specificity is irrelevant because only precursor mass matters.

Many PTMs occur preferentially on specific amino acids, which helps localize them.

Residue specificity only applies to artificial modifications, not biological PTMs.

Q3. What is the main purpose of using Unimod in PTM analysis?

To predict protein tertiary structure from MS2 spectra.

To provide a database of known modifications, their masses, and compositions.

To digest proteins into peptides automatically.

To remove unmodified peptides before LC-MS analysis.

Q4. Why is carbamidomethylation of cysteine usually treated as a fixed modification in bottom-up proteomics?

Because it naturally occurs on all cysteines in living cells.

Because sample preparation intentionally modifies cysteines after reduction and alkylation.

Because it only occurs on phosphorylated serines.

Because it removes cysteine residues from the peptide sequence.

Q5. What is the main reason cysteine residues are alkylated after reduction?

To make cysteines fluorescent by default.

To prevent free thiols from reacting unpredictably or reforming disulfides.

To convert cysteine into serine.

To increase the peptide charge state to exactly 3+.

Q6. In MS/MS-based PTM localization, what happens to fragment ions that contain the modified residue?

They disappear in every case.

They shift in mass according to the PTM delta mass.

They always become neutral molecules.

They always become y-ions regardless of fragmentation direction.

Q7. If a y-ion series is read from the C-terminus, what does a shift beginning at y2 suggest?

The modification is included in the C-terminal two-residue fragment.

The modification must be at the N-terminal residue.

The peptide has no modification.

Only the precursor ion is modified, not the fragments.

Q8. In the transcript example, why does a mass shift from approximately 318 to 398 support phosphorylation?

Because the difference is about 16 Da, matching oxidation.

Because the difference is about 80 Da, matching phosphorylation.

Because the difference is about 57 Da, matching carbamidomethylation.

Because the difference is zero, showing no modification.

Q9. Why is the incorrect figure in the transcript considered wrong?

Because b-ions should always be yellow.

Because the last fragment peak should also shift if it contains the modification.

Because acetylation cannot occur on lysine.

Because MS2 spectra never contain fragment ions.

Q10. Why can longer peptides more often produce doubly charged fragment ions?

Because longer peptides contain more potential ionizable groups.

Because longer peptides cannot fragment.

Because longer peptides lose all basic residues.

Because only short peptides can accept protons.

Q11. Why does including many possible PTMs in a database search make analysis harder?

It reduces the number of candidate peptide interpretations to one.

It increases the search space and can raise the risk of false identifications.

It prevents the detection of any modified peptide.

It makes all fragments singly charged.

Q12. What is the purpose of phosphopeptide enrichment methods such as TiO2 or IMAC?

To selectively retain phosphorylated peptides and reduce sample complexity.

To chemically remove phosphate groups before MS.

To convert serine into cysteine.

To force all peptides to become glycosylated.

Q13. What does the transcript mean by the trade-off between complexity and depth in MS?

The more complex the sample, the easier it is to identify every molecule deeply.

Reducing sample complexity can allow deeper analysis of a selected class of molecules.

Depth and complexity are unrelated in proteomics.

MS can always measure every peptide equally well in one run.

Q14. Why is glycoproteomics described as especially challenging?

Glycans are always linear and simple.

Glycans have complex branching, many possible structures, and can fragment in labile ways.

Glycosylation has no mass effect.

Glycans only occur on cysteine after alkylation.

Q15. Post-translational modifications are introduced after protein synthesis.

True

False

Q16. Phosphorylation commonly adds a mass of approximately 79.966 Da.

True

False

Q17. Ubiquitination can act as a signal for protein degradation by the proteasome.

True

False

Q18. All PTMs are biological modifications that naturally occur in cells.

True

False

Q19. Carbamidomethylation of cysteine adds approximately 57 Da.

True

False

Q20. A fixed modification means the software assumes that modification is present at every specified residue of that type.

True

False

Q21. In fragment ion interpretation, peak intensity is usually more important than m/z position for identifying where a PTM is located.

True

False

Q22. B-ion series are read from the N-terminus, while y-ion series are read from the C-terminus.

True

False

Q23. If only fragments before a modification site are examined, they may appear unchanged compared with the unmodified reference spectrum.

True

False

Q24. A missing fragment peak, such as a missing b8 ion, always means the peptide sequence assignment is impossible.

True

False

Q25. Searching for modified peptides is essentially like sequential walking with an expanded mass list that includes modified residue masses.

True

False

Q26. When no prior information is available about possible PTMs, the search space becomes smaller and easier to analyze.

True

False

Q27. Enrichment methods can improve detection of rare modified peptides by removing many unmodified peptides.

True

False

Q28. Glycans are described as labile because they are stable under all conventional fragmentation conditions.

True

False

Q29. Comparing PTM patterns between control and treated samples can reveal changes in cellular signaling or regulation.

True

False